BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: Completion of Placement, page-13

  1. 1,167 Posts.
    lightbulb Created with Sketch. 448
    Am I wrong in reading that there is a caveat on placement funds that the SP must withhold within certain parameters for a period of time and failing to do so will negate the contract ? And that deterioration of general market conditions may compromise the company’s ability to guarantee this despite the inherent potential of the company’s pipeline of products ?

    Anyone familiar with CR conditions ?
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.